Syndax Pharmaceuticals(DE:1T3)
€8.21-0.25 (-2.95%)
DE:1T3
Syndax Pharmaceuticals earnings date
€8.21
At close:-0.25 (-2.95%)
Syndax Pharmaceuticals (1T3) Q3 2022 Earnings Report
4 Followers
DE:1T3 Q3 2022 EPS Results
- Actual EPS
- -EUR 0.52
- Consensus EPS
- -EUR 0.57
- Beat/Miss
- Beat by +EUR 0.05
- One Year Ago EPS
- -EUR 0.36
DE:1T3 Q3 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 672.60K
- Beat/Miss
- Missed by -EUR 672.60K
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/03/2022
- Time
- After Close
- Conference Call
- Thursday, November 3, 2022
DE:1T3 Upcoming Earnings
Syndax Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:1T3 Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1T3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.47- | -0.7 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.45-0.49 | -0.63 | 21.43% (+0.13) | |
| Aug 04, 2026 | 2026 (Q2) | -0.40-0.49 | -0.74 | 33.73% (+0.25) | |
| Apr 30, 2026 | 2026 (Q1) | -0.55-0.43 | -0.88 | 51.02% (+0.45) | |
| Feb 26, 2026 | 2025 (Q4) | -0.52-0.70 | -0.99 | 29.09% (+0.29) | |
| Nov 03, 2025 | 2025 (Q3) | -0.65-0.63 | -0.88 | 28.57% (+0.25) | |
| Aug 04, 2025 | 2025 (Q2) | -0.91-0.74 | -0.72 | -3.75% (-0.03) | |
| May 05, 2025 | 2025 (Q1) | -1.12-0.88 | -0.76 | -15.29% (-0.12) | |
| Mar 03, 2025 | 2024 (Q4) | -0.75-0.99 | -0.9 | -10.00% (-0.09) | |
| Nov 05, 2024 | 2024 (Q3) | -0.96-0.88 | -0.65 | -34.25% (-0.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


